Drug Approval | March 22, 2023
Zydus granted Orphan Drug Designation by USFDA for ZYIL1
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The observations are procedural in nature
He is Proficient in overseeing and leading teams for running successful business operations
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
The facility has been set up to manufacture tuberculosis testing cartridges
Proposed combination enhances Pfizer’s position as a leading company in oncology
Subscribe To Our Newsletter & Stay Updated
